New pre-clinical SHIV remission study shows progress in delaying viral load rebound
Predicting microbial interactions in the human gut
1 March 2021Birthweight strongly linked to type 2 diabetes risk in adulthood
1 March 2021New pre-clinical SHIV remission study shows progress in delaying viral load rebound
A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.
